期刊文献+

血清白细胞介素-33检测对类风湿关节炎肺间质病变的价值探讨 被引量:1

Correlation studies of serum interleukin-33 and rheumatoid arthritis-associated interstitial lung disease
原文传递
导出
摘要 目的探讨血清白细胞介素-33(IL-33)与类风湿关节炎(RA)合并肺间质病变(ILD)的相关性。方法纳入RA患者177例,分为RA合并ILD(RA-ILD)组47例与单纯RA组130例,观察并比较2组肺功能等相关实验室指标。测定2组的血清IL-33水平,采用Pearson相关分析探讨IL-33水平及其与相关变量间的关系。结果与RA组相比,RA-ILD组血清IL-33水平更高,差异有统计学意义(P<0.05)。与RA组比较,RA-ILD组的肺活量占预计值百分比(VC%)、用力肺活量占预计值百分比(FVC%)和一氧化碳弥散量(DLCO)均显著降低(P<0.05)。RA-ILD组中36例(占76.6%)出现动脉血氧分压(Pa O2)降低,且RA-ILD组Pa O2明显低于RA组(P<0.05)。RA-ILD组红细胞沉降率(ESR)、C反应蛋白(CRP)、类风湿因子(RF)和抗环瓜氨酸多肽抗体(ACPA)水平明显低于RA组(P均<0.05)。相关性分析显示,血清IL-33水平与RF、ACPA滴度呈正相关(r分别为0.90和0.61,P均<0.05),与DLCO水平呈负相关(r=-0.77,P<0.05)。血清IL-33水平与ESR、CRP和Pa O2无相关性。结论 IL-33参与RA的发病过程,且可能与RA-ILD的发病相关。 Objective To study the relationship between serum interleukin-33( IL-33) and rheumatoid arthritis( RA)complicated with intemtitial lung disease( RA-ILD). Methods 177 cases newly diagnosed as RA were enrolled and were divided into RA group( n = 130) and RA-ILD group( n = 47). The clinical data of the three groups were collected and the serum level of IL-33 was dectected. Pearson's correlation analysis was applied to explore the relationship between serum level of IL-33 and related variables. Results The level of IL-33 in RA-ILD group was higher and the levels of VC%,FVC% and DLCO were significantly lower than those in RA group( P〈0. 05). There were 36 cases( 76. 6%) in RA-ILD group with reduced Pa O2,and the level of Pa O2 in RA-ILD group was obviously lower than that of RA group( P〈0. 05).The serum level of IL-33 was positively correlated with RF and ACPA( r = 0. 90,0. 61,P〈0. 05),and the serum level of IL-33 was negaitively correlated with DLCO( r =- 0. 77,P〈0. 05). Conclusions IL-33 participates in the pathogenesis of RA and may be involved in the pathogenesis of RA-ILD.
作者 陈波
出处 《实用老年医学》 CAS 2015年第6期467-470,共4页 Practical Geriatrics
关键词 类风湿关节炎 间质性肺疾病 白细胞介素-33 rheumatoid arthritis interstitial lung diseases interleukins-33
  • 相关文献

参考文献14

  • 1李博,叶志中,陈雅硕,何伟珍,孔卫红,谢燕,张丽君,李剑松.老年起病的类风湿关节炎血清中葡萄糖6磷酸异构酶的临床意义[J].实用老年医学,2011,25(5):382-383. 被引量:2
  • 2李晶,侯晓华.基于系统生物医学理论的老年类风湿性关节炎的免疫诊治[J].实用老年医学,2010,24(3):191-195. 被引量:2
  • 3Fischer A, Brown KK.Interstitial lung disease in undifferen- tiated forms of connective tissue disease [ J ]. Arthritis Care Res ( Hoboken), 2014.Epub ahead of print.
  • 4Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor- related protein ST2 and induces T helper type 2-associated cytokines [ J ].Immunity, 2005, 23 (5) :479-490.
  • 5Girard JP. A direct inhibitor of HMGB1 cytokine[ J] .Chem- Biol, 2007, 14(4) :345-347.
  • 6Ameh FC, Edworth SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classifi- cation of rheumatoid arthritis [ J ]. Arthritis Rheum, 1988,31 (5) :315-324.
  • 7Demedts M, Costabel U.ArpS/ERS international muhidiscipli- nary consensus classification of the idiopathic international pneumonias[ J] .Eur Respir J,2002,19( 11 ) :794-796.
  • 8类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1290
  • 9侯杰.现代肺弥漫性疾病学[M].北京:人民军区出版社,2005:419-420.
  • 10Sanada S, Hakuno D, Hiqqins LJ, et al.IL-33 and ST2 com- prise a critical biomechanically induced and cardioprotective signaling system [ J] .Clin Invest, 2007,117 (6) :1538-1549.

二级参考文献31

  • 1鲍春德,叶萍,陈晓翔,叶霜.血清中6-磷酸葡萄糖异构酶抗原升高在类风湿关节炎中的意义探讨[J].中华风湿病学杂志,2005,9(5):277-279. 被引量:80
  • 2Coaccioli S,Pinoca F,Giuliani M,et al.Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations,their soluble receptors and soluble receptor of interleukin-2[J].Clin Ter,2007,158(4):303-306.
  • 3Filipowicz-Sosnowska A,Rupiński R.Elderly onset rheumatoid arthritis[J].Pol Arch Med Wewn,2008,118 (Suppl):36-42.
  • 4Tutuncu Z,Kavanaugh A.Rheumatic disease in the elderly:rheumatoid arthritis[J].Rheum Dis Clin North Am,2007,33(1):57-70.
  • 5Tutuncu Z,Kavanaugh A.Rheumatic disease in the elderly:rheumatoid arthritis[J].Clin Geriatr Med,2005,21(3):513-525.
  • 6Ceccato F,Roverano S,Barrionuevo A,et al.The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica[J].Clin Rheumatol,2006,25(6):854-857.
  • 7Lopez-Hoyos M,Ruiz de Alegria C,Blanco R,et al.Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica[J].Rheumatology (Oxford),2004,43(5):655-657.
  • 8Huscher D,Sengler C,Ziegler S,et al.Rheumatoid arthritis in the elderly[J].Dtsch Med Wochenschr,2009,134(36):1766-1770.
  • 9Ursum J,Britsemmer K,van Schaardenburg D,et al.High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis[J].Ann Rheum Dis,2009,68(9):1512-1513.
  • 10Shiozawa S.Polymyalgia rheumatica and elderly-onset rheumatoid arthritis[J].Intern Med,2002,41(8):605.

共引文献1295

同被引文献31

  • 1Schett G,Zwerina J, Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis[J]. Ann Rheum Dis, 2008,67 (7) : 909-916.
  • 2Mavropoulos A, Orfanidou T, Liaskos C, et al. p38 mitogen-activated pro- tein kinase (p38 MAPK)-mediated autoimmunity:lessons to learn from ANCA vasculitis and pemphigus vulgaris[J]. Autoimmun Rev,2013,12 (5) :580-590.
  • 3Patterson H, Nibbs R, Meinnes I, et al. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases[J]. Clin Exp Immunol, 2014,176(1 ):1-10.
  • 4Han J, Lee JD, Bibhs L, et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells[J]. Science, 1994,265 (5173) : 808-811.
  • 5Ferreiro I, Joaquin M, Islam A, et al. Whole genome analysis of p38 SAPK- mediated gene expression upon stress[J]. BMC Genomics, 2010,11:144.
  • 6Terajima M ,Inoue T, Magari K, et al. Anti-inflammatory effect and selec- tivity profile of AS1940477,a novel and potent p38 mitogen-activated protein kinase inhibitor[J]. Eur J Pharmacol, 2013,698 ( 1/2/3 ) :455-462.
  • 7Simmons DL. Targeting kinases:a new approach to treating inflammatory rheumatic diseases[J]. Curr Opin Pharmacol, 2013,13 (3):426-434.
  • 8Cuadrado A,Nebreda AR. Mechanisms and functions of p38 MAPK sig- nalling[J]. Biochem J, 2010,429 ( 3 ) : 403-417.
  • 9Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK[J]. Oncogene, 2007,26 (22) : 3214-3226.
  • 10Gaestel M. What goes up must come down ; molecular basis of MAPKAP kinasc 2/3-dependent regulation of the inflammatory response and its in- hibition[J]. Biol Chem, 2013,394 ( 10 ): 1301 - 1315.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部